Screener
Bio-Rad Laboratories BIO CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Proceeds from (payments for) forward foreign exchange contracts, net | 9.9 | (8.3) |
| Net cash provided by operating activities | 108.1 | 129.9 |
| Cash flows from investing activities: | ||
| Payments for purchases of property, plant and equipment | (30.0) | (34.4) |
| Proceeds from dispositions of property, plant and equipment | 0.1 | — |
| Payments for purchases of marketable securities and investments | (226.1) | (153.4) |
| Proceeds from sales of marketable securities and investments | 145.1 | 171.2 |
| Proceeds from maturities of marketable securities and investments | 17.7 | 19.5 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's capex?
- Bio-Rad Laboratories (BIO) reported capex of $30M in Q1 2026.
- How has Bio-Rad Laboratories's capex changed year-over-year?
- Bio-Rad Laboratories's capex decreased by 12.8% year-over-year, from $34.4M to $30M.
- What is the long-term trend for Bio-Rad Laboratories's capex?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's capex has grown at a 4.2% compound annual growth rate (CAGR), from $133.75M to $157.6M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Bio-Rad Laboratories's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude